Trial intelligence / Profile preview

Lasix effect in kidney transplant patients

IRCT2016042023559N3Phase 2Completed

Sponsor
Tabriz University of Medical Sciences
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of furosemide in end-stage kidney disease (ESKD), sponsored by Tabriz University of Medical Sciences. Started Mar 2016; status: completed.

02

Drugs

furosemide
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on IRCT2016042023559N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016042023559N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call